Seattle Times - Cell Therapeutics shares fell 17.4 percent Thursday after the Seattle biotechnology company said it had issued 6.85 million shares of stock to cancel $9.1 million of convertible debt due in June 2008. The stock closed down 29 cents at $1.38. The ...
